Oluwafemi Oguntibeju

Prof Oluwafemi.O Oguntibeju is an Associate Professor and Group Leader (Nutrition and Chronic Disease Research Unit) at the Oxidative Stress Research Centre in the Department of Biomedical Sciences, Faculty of Health & Wellness, Cape Peninsula University of Technology Bellville, South Africa. He lectures and supervises postgraduate students and collaborates with national and international scientists. Over the years, he has been involved in the field of nutrition and HIV/AIDS and related-public health issues but more recently on diabetes. He has published over 90 scientific papers in peer-reviewed journals, presented over 30 papers at national and international conferences and reviewed manuscripts for over 30 international scientific journals. He has received various awards such as the Gold Research Excellence Award at his current university. Prof O.O Oguntibeju is a National Research Foundation (NRF) C-rated researcher and holds a master degree in Biochemistry from the University of Ibadan, Nigeria and a doctoral degree in Biomedical Science at the Central University of Technology, Bloemfontein, South Africa. He is a Chartered Scientist (CSci, UK) and Fellow of the Institute of Biomedical Science, London. He enjoys reading and music and he is married to Faustina and has four children.

3books edited

4chapters authored

Latest work with IntechOpen by Oluwafemi Oguntibeju

The fundamental treatment and management goals in diabetes mellitus are to control and normalize blood glucose levels and to prevent diabetic complications. It also includes maintaining normal growth and development and normal body weight. Proper diet, regular exercise, weight control and different therapeutic agents are the mainstays of diabetic care and management. Weight reduction and exercise have been shown to improve tissue sensitivity to insulin and allow its proper use by target tissues. It is obvious that medical management and goals of therapy for diabetes mellitus have changed since the publication of the Diabetes Control and Complications Trial in 1993. Recent studies have shown that the risk of developing retinopathy can decrease by 76% in properly managed diabetic patients when compared to control group and that clinical and laboratory signs and symptoms of nephropathy and neuropathy can also decrease by 54 to 60%. Modern approaches to the management of diabetes mellitus embrace holistic options and this book addressed various approaches in the management of diabetes mellitus.

Go to the book